Delivery Order SPE2DR25D1205-SPE2DR26F1AE5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,910.52 to AmerisourceBergen Drug Corp for the supply of Testosterone 1% (50 mg/5 g) in unit dose packages of 5 grams. The contract was awarded on January 14, 2026, with an ultimate completion date of January 15, 2026, and utilizes firm fixed-price pricing with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,011.37 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages. The contract, awarded on December 19, 2025, with an ultimate completion date of December 22, 2025, represents a firm fixed-price delivery order with no set-aside designation. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,566.76 to AmerisourceBergen Drug Corp for the supply of Testosterone 1% (25 mg/2.5 g) in 2.5 gram packages. The contract was executed as a firm fixed-price delivery order on January 6, 2026, with an ultimate completion date of January 7, 2026, and no set-aside designation was applied. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,185.93 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The order is scheduled for completion by September 18, 2025, and will be fulfilled from the contractor's Conshohocken,...
- The Defense Logistics Agency awarded a $1,296.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with an ultimate completion date of January 13, 2026. This non-set-aside contract represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.999 billion through December 2026. The place of performance is in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a ceiling value of $1,296.00 and a completion date of January 6, 2026. This contract utilizes a firm fixed price structure and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency (DLA) awarded a $3,599.50 delivery order to AmerisourceBergen Drug Corp for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with an ultimate completion date of September 26, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. As a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a ceiling value of $1,976.82. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The work is scheduled for completion by August 22, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,077.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (50 mg/5 g) in unit dose 5-gram packages. The contract, awarded December 31, 2025, with an ultimate completion date of January 2, 2026, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,828.25 to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packages of 5 grams. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by January 13, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as the prime...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F1AE5Delivery Order
The Defense Logistics Agency awarded a $1,370.06 delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 21, 2026, and represents a task order under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order operates as a child contract under AmerisourceBergen Drug Corp, which functions as a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen). AmerisourceBergen holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, serving as the comprehensive vehicle for supplying pharmaceutical products and medical supplies to military healthcare systems globally. The hormone treatment commodity included in this task order exemplifies the company's extensive portfolio of pharmaceutical deliveries supporting federal medical procurement needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 1/19/26 |